Uro-MP (Method Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the Uro-MP drug offered from Method Pharmaceuticals, LLC. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Method Pharmaceuticals, LLC
NON-PROPRIETARY NAME: Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine Sulfate
SUBSTANCE NAME: METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2014-12-01
END MARKETING DATE: 0000-00-00


Uro-MP HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUro-MP from Method Pharmaceuticals, LLC
LABELER NAME: Method Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 118; 40.8; 36; 10; .12(mg/1; mg/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 2014-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58657-456_24d6c364-4ea8-2e42-e054-00144ff8d46c
PRODUCT NDC: 58657-456
APPLICATION NUMBER:

Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AvKARE, Inc.UroAv-81
Method Pharmaceuticals, LLCUro-MP